Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A dose ranging study of the pharmacokinetics, safety, and preliminary efficacy of lamivudine in children and adolescents with chronic hepatitis B.
Sokal EM, Roberts EA, Mieli-Vergani G, McPhillips P, Johnson M, Barber J, Dallow N, Boxall E, Kelly D. Sokal EM, et al. Among authors: mcphillips p. Antimicrob Agents Chemother. 2000 Mar;44(3):590-7. doi: 10.1128/AAC.44.3.590-597.2000. Antimicrob Agents Chemother. 2000. PMID: 10681323 Free PMC article. Clinical Trial.
Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders.
Schiff ER, Dienstag JL, Karayalcin S, Grimm IS, Perrillo RP, Husa P, de Man RA, Goodman Z, Condreay LD, Crowther LM, Woessner MA, McPhillips PJ, Brown NA; International Lamivudine Investigator Group. Schiff ER, et al. Among authors: mcphillips pj. J Hepatol. 2003 Jun;38(6):818-26. doi: 10.1016/s0168-8278(03)00076-x. J Hepatol. 2003. PMID: 12763376 Clinical Trial.